These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 17452419

  • 1. Centrally administered nociceptin/orphanin FQ (N/OFQ) evokes bradycardia, hypotension, and diuresis in mice via activation of central N/OFQ peptide receptors.
    Burmeister MA, Kapusta DR.
    J Pharmacol Exp Ther; 2007 Jul; 322(1):324-31. PubMed ID: 17452419
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Central G-alpha subunit protein-mediated control of cardiovascular function, urine output, and vasopressin secretion in conscious Sprague-Dawley rats.
    Wainford RD, Kurtz K, Kapusta DR.
    Am J Physiol Regul Integr Comp Physiol; 2008 Aug; 295(2):R535-42. PubMed ID: 18525017
    [Abstract] [Full Text] [Related]

  • 5. Central administration of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)-NH2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats.
    Kapusta DR, Chang JK, Kenigs VA.
    J Pharmacol Exp Ther; 1999 Apr; 289(1):173-80. PubMed ID: 10087001
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats.
    Leggett JD, Harbuz MS, Jessop DS, Fulford AJ.
    Neuroscience; 2006 Sep 15; 141(4):2051-7. PubMed ID: 16784820
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chronic high-NaCl intake prolongs the cardiorenal responses to central N/OFQ and produces regional changes in the endogenous brain NOP receptor system.
    Wainford RD, Kapusta DR.
    Am J Physiol Regul Integr Comp Physiol; 2009 Feb 15; 296(2):R280-8. PubMed ID: 18987291
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nociceptin/orphanin FQ and related peptides reduce the increase in plasma corticosterone elicited in mice by an intracerebroventricular injection.
    Le Cudennec C, Naudin B, Do Rego JC, Costentin J.
    Life Sci; 2002 Nov 29; 72(2):163-71. PubMed ID: 12417250
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM, Statnick MA, Rorick-Kehn LM, Pintar JE, Ansonoff M, Chen Y, Tucker RC, Ciccocioppo R.
    Pharmacol Ther; 2014 Mar 29; 141(3):283-99. PubMed ID: 24189487
    [Abstract] [Full Text] [Related]

  • 17. UFP-101, a high affinity antagonist for the nociceptin/orphanin FQ receptor: radioligand and GTPgamma(35)S binding studies.
    McDonald J, Calo G, Guerrini R, Lambert DG.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb 29; 367(2):183-7. PubMed ID: 12595960
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ).
    Kapusta DR, Sezen SF, Chang JK, Lippton H, Kenigs VA.
    Life Sci; 1997 Feb 29; 60(1):PL15-21. PubMed ID: 8995537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.